[go: up one dir, main page]

Hummer et al., 2022 - Google Patents

Optimization of topical formulations using a combination of in vitro methods to quantify the transdermal passive diffusion of drugs

Hummer et al., 2022

Document ID
5860163339352383981
Author
Hummer J
Birngruber T
Sinner F
Page L
Toner F
Roper C
Moore D
Baker M
Bettex M
Publication year
Publication venue
International Journal of Pharmaceutics

External Links

Snippet

This paper describes a new approach to the early-stage optimization of topical products and selection of lead formulation candidates. It demonstrates the application of open flow microperfusion in vitro in conjunction with the Franz diffusion cell to compare time-resolved …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material

Similar Documents

Publication Publication Date Title
Hummer et al. Optimization of topical formulations using a combination of in vitro methods to quantify the transdermal passive diffusion of drugs
Kretsos et al. Partitioning, diffusivity and clearance of skin permeants in mammalian dermis
Dancik et al. Convective transport of highly plasma protein bound drugs facilitates direct penetration into deep tissues after topical application
Herkenne et al. Ibuprofen transport into and through skin from topical formulations: in vitro–in vivo comparison
Miller et al. The solubility–permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation
Holmgaard et al. Comparison of open-flow microperfusion and microdialysis methodologies when sampling topically applied fentanyl and benzoic acid in human dermis ex vivo
Zhang et al. Skin solubility determines maximum transepidermal flux for similar size molecules
Anissimov et al. Modelling dermal drug distribution after topical application in human
Rapalli et al. Revisiting techniques to evaluate drug permeation through skin
Alonso et al. Prediction of the skin permeability of topical drugs using in silico and in vitro models
Gajula et al. In-silico skin model: a multiscale simulation study of drug transport
Paloncýová et al. Rationalization of reduced penetration of drugs through ceramide gel phase membrane
Patel et al. Research techniques made simple: Drug delivery techniques, Part 2: Commonly used techniques to assess topical drug bioavailability
Waters et al. Modelling skin permeability with micellar liquid chromatography
Khalil et al. Glucose partition coefficient and diffusivity in the lower skin layers
Yamamoto et al. Prediction of human pharmacokinetic profile after transdermal drug application using excised human skin
Selzer et al. Finite dose skin mass balance including the lateral part: comparison between experiment, pharmacokinetic modeling and diffusion models
Oh et al. In vitro skin permeation methodology for over-the-counter topical dermatologic products
Fasano et al. Dermal penetration of propylene glycols: Measured absorption across human abdominal skin in vitro and comparison with a QSAR model
Yoshimatsu et al. Prediction of human percutaneous absorption from in vitro and in vivo animal experiments
Maciel Tabosa et al. Quantification of chemical uptake into the skin by vibrational spectroscopies and stratum corneum sampling
Moore et al. Reverse iontophoresis: Noninvasive assessment of topical drug bioavailability
Ruan et al. A skin pharmacokinetics study of permeation enhancers: the root cause of dynamic enhancement effect on in vivo drug permeation
Soriano-Meseguer et al. Optimization of experimental conditions for skin-PAMPA measurements
Lee et al. Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay